| Authors: |
Duncan P; Centre for Academic Primary Care, University of Bristol, Bristol, UK polly.duncan@bristol.ac.uk.; Bristol Vaccine Centre, Schools of Population Health Science and Cellular and Molecular Medicine, University of Bristol, Bristol, UK., Mears R; Centre for Academic Primary Care, University of Bristol, Bristol, UK.; Bristol Vaccine Centre, Schools of Population Health Science and Cellular and Molecular Medicine, University of Bristol, Bristol, UK., Begier E; Global Respiratory Vaccines, Medical & Scientific Affairs, Pfizer Inc, Collegeville, PA, US., Rouhbakhsh Halvaei S; Bristol Vaccine Centre, Schools of Population Health Science and Cellular and Molecular Medicine, University of Bristol, Bristol, UK., Southern J; Evidence Generation, Pfizer Inc, Collegeville, PA, US., Porter SB; Bristol Vaccine Centre, Schools of Population Health Science and Cellular and Molecular Medicine, University of Bristol, Bristol, UK., Hubler R; Evidence Generation, Pfizer Inc, Collegeville, PA, US., Oben G; Bristol Vaccine Centre, Schools of Population Health Science and Cellular and Molecular Medicine, University of Bristol, Bristol, UK., Qian G; Bristol Vaccine Centre, Schools of Population Health Science and Cellular and Molecular Medicine, University of Bristol, Bristol, UK., Lahuerta M; Global Respiratory Vaccines, Medical & Scientific Affairs, Pfizer Inc, Collegeville, PA, US., Davis T; Centre for Academic Primary Care, University of Bristol, Bristol, UK., Campling J; Vaccines Medical Affairs, Pfizer Ltd, Tadworth, UK., Dawson S; Centre for Academic Primary Care, University of Bristol, Bristol, UK., Christensen H; Bristol Vaccine Centre, Schools of Population Health Science and Cellular and Molecular Medicine, University of Bristol, Bristol, UK., Oliver J; Bristol Vaccine Centre, Schools of Population Health Science and Cellular and Molecular Medicine, University of Bristol, Bristol, UK., Morales-Aza B; Bristol Vaccine Centre, Schools of Population Health Science and Cellular and Molecular Medicine, University of Bristol, Bristol, UK., Pan K; EvGen Statistics, Pfizer Research and Development, Pfizer Inc, Collegeville, PA, US., Gray S; Evidence Generation, Pfizer Inc, Collegeville, PA, US., Hyams C; Bristol Vaccine Centre, Schools of Population Health Science and Cellular and Molecular Medicine, University of Bristol, Bristol, UK., Danon L; School of Engineering Mathematics and Technology, University of Bristol, Bristol, UK., Gessner BD; Global Respiratory Vaccines, Medical & Scientific Affairs, Pfizer Inc, Collegeville, PA, US.; West of England NIHR Clinical Research Network, Bristol, UK., Finn A; Bristol Vaccine Centre, Schools of Population Health Science and Cellular and Molecular Medicine, University of Bristol, Bristol, UK., Hay AD; Centre for Academic Primary Care, University of Bristol, Bristol, UK. |
